Announcement from the International Committee for 2025
-
The "Regular Meeting with the German Association of the Research-based Pharmaceutical Industry (vfa)
-
Special Session at the "12th Nikkei-FT Conference on Infectious Diseases
～The 11th Nikkei-FT Conference on Infectious Diseases held -
Cover Letter Template Created for Use in the Simplified Review System in the Asian Region
-
Report on the Pharmaceutical Manufacturers Association of Japan Media Forum "Two Major Issues in Countermeasures against Infectious Diseases: Consideration of Countermeasures against Drug-Resistant Bacteria and Proper Understanding of Immunization
-
Report on the "3rd Meeting of the Japan-Malaysia Drug Regulatory Agency (J-MRADRA)", held at the Pharmaceutical Affairs Agency of Japan (PAPMA) in Tokyo, Japan
International Committee Chairman Murakami strengthens communication to the international community and establishes a new organization. -
The 3rd Japan-Malaysia Symposium on Drug Regulation
Active discussions were held between the two countries on the themes of "Real World Data, Risk Management Plan, Expedited Review (Simplified Review) System, and Clinical Trials. -
The 6th Japan-Korea Symposium on Pharmaceutical Regulation was held.
Pharmaceutical regulatory authorities and industries from Japan and Korea gathered to discuss common issues -
Meeting with Pharmaceuticals and Medical Devices Agency (PMDA), National Cancer Center (NCC), and National Institute of Health Risk Management (JIHS)" held to improve the clinical trial environment in Asia
-
International Committee" was introduced in the Pharmaceutical Manufacturers Association of Japan Newsletter No.225.
-
Held a regular meeting with the French Association of the Pharmaceutical Industry (Leem).
-
Held regular meeting with the European Federation of Pharmaceutical Industries and Associations (EFPIA).
-
The 2nd Neglected Tropical Diseases Contest" was held.
-
The "Regular Meeting with the German Association of the Research-based Pharmaceutical Industry (vfa)
-
Special session held at the "11th Nikkei-FT Conference on Infectious Diseases
Establishment of an Infectious Drug Discovery Ecosystem - Toward the Implementation Phase